FDA approves Zimrixby (rituximab-cdxx) - FDA New Drug Approvals - Nundina

Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Zimrixby (rituximab-cdxx)FDA approves Zimrixby (rituximab-cdxx)31 July 2026The FDA approved Zimrixby (rituximab-cdxx), a biologic from DR Reddys Labs SA. Form: Injection. Application BLA761376.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)